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Abstract: Muscle atrophy alone is insufficient to explain the significant decline in contractile force of skeletal muscle
during normal aging. One contributing factor to decreased contractile force in aging skeletal muscle could be compromised
excitation‐contraction (E‐C) coupling, without sufficient available Ca2+ to allow for repetitive muscle contractility, skeletal
muscles naturally become weaker. Using biophysical approaches, we previously showed that store‐operated Ca2+ entry
(SOCE) is compromised in aged skeletal muscle but not in young ones. While important, a missing component from
previous studies is whether or not SOCE function correlates with contractile function during aging. Here we test the
contribution of extracellular Ca2+ to contractile function of skeletal muscle during aging. First, we demonstrate graded
coupling between SR Ca2+ release channel‐mediated Ca2+ release and activation of SOCE. Inhibition of SOCE produced
significant reduction of contractile force in young skeletal muscle, particularly at high frequency stimulation, and such
effects were completely absent in aged skeletal muscle. Our data indicate that SOCE contributes to the normal
physiological contractile response of young healthy skeletal muscle and that defective extracellular Ca2+ entry through
SOCE contributes to the reduced contractile force characteristic of aged skeletal muscle.

INTRODUCTION

strength that develops despite dietary interventions and
increased physical activity [6,7]. The physical,
psychological and socio-economic impact of sarcopenia
is largely underestimated despite the fact that it is a
leading contributor to debilitating injuries due to
repetitive falls, loss of independence, and a reduced
quality of life in the elderly population [4].

Aging is a complex biological process marked by the
gradual decline of a multitude of physiological
processes [1-5]. Some functional changes, such as
decreased muscular strength, have a tremendous impact
on the quality of life. Normal aging involves sarcopenia,
a combination of atrophy and decreased muscular
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To examine the contribution of SOCE to muscle
contractile function during aging, we made use of ex
vivo contractility assays, in which the components of
the extracellular milieu surrounding isolated anatomical
muscles can be precisely manipulated. This allowed use
of pharmacological and experimental manipulations to
alter the function of SOCE in order to define its
physiological role in young and aged skeletal muscle.
We found that reagents that prevent [Ca2+]o entry reduce
contractile force in skeletal muscle, an effect that was
more prominent at high frequency stimulation as
compared to lower frequencies of stimulation, and that
SOCE is a robust mechanism of [Ca2+]o entry in young,
healthy skeletal muscle. Of utmost importance, we also
demonstrate that SOCE is compromised in aged skeletal
muscle, and that loss of this physiological component
contributes to at least a part of the decreased contractile
force generation typical of aged muscle.

Understanding the cellular mechanisms that
contribute to sarcopenia is essential for the
development of effective treatments and improved
care for the elderly.
While many cellular modifications [8-13] may
contribute to muscle aging, excitation-contraction (E-C)
coupling is an elemental process that must be
considered because it is so integral to the control of
muscle contractility. E-C coupling requires the close
coordination of extracellular Ca2+ ([Ca2+]o) entry or
voltage-sensing changes with Ca2+ release from the
principal
intracellular
storage
organelle,
the
sarcoplasmic reticulum (SR). Changes in E-C coupling
machinery may act as causative factors for, or adaptive
mechanisms in, muscle aging that directly contribute to
muscle weakness. Decreased muscle function during
aging has been associated with muscle fiber
denervation, loss of motor units, and motor unit
remodeling. Moreover, altered function of several triad
junction proteins involved in the regulation and
transduction of E-C coupling has been shown to
contribute to disrupted Ca2+ homeostasis in aged
skeletal muscle [14-17].

Our novel studies that now link SOCE with muscle
contractile function, suggest that manipulation of SOCE
may present a therapeutically valid target for
improvement of contractile function and, potentially the
amelioration of muscle weakness seen during aging.

RESULTS

Thus, reduced homeostatic capacity for intracellular
Ca2+ movement may underlie the progression of
sarcopenia and contractile dysfunction during muscle
aging. We have previously demonstrated that changes
in aged skeletal muscle Ca2+ homeostasis are
accompanied by distinct modification of the structure
and protein composition of triad junctional complexes.
We found that expression of mitsugumin 29 (MG29), a
triad junction protein, drastically decreases with aging
and that skeletal muscle from adolescent MG29
knockout mice contain many of the phenotypic changes
we observe in aged skeletal muscle, including defective
store-operated Ca2+ entry (SOCE) [16-18]. SOCE is an
important mechanism linking [Ca2+]o entry and
intracellular Ca2+ storage, in particular during the
repetitive cycles of E-C coupling when a reduced SR
Ca2+ store necessitates the activation of SOCE. Several
previous studies have demonstrated that SOCE plays a
role in muscle fatigue [19-22] as part of a functional
stress response in skeletal muscle [18].

Extracellular Ca2+ contributes to tetanic contractile
force in skeletal muscle
In the first series of ex vivo contractility experiments, it
was critical to validate that muscle preparation
deterioration or run-down did not play any role in our
results. Fig. 1 shows an example that is representative
of the muscle preparations used in our studies. Fig. 1A
demonstrates that our preparations can undergo very
lengthy protocols without any detectable run-down of
contractile force. When a single muscle fiber is
dissected from the intact muscle, it produces a maximal
tetanic force that is equivalent to the amount force
produced by the same fiber after it is permeabilized
with Triton X-100 and maximally activated with
calcium (Figs. 1B, C). These results illustrate the
robustness of our preparations and the validity of our
force calibrations.
SOCE is dependent upon extracellular calcium. To
begin testing the role of extracellular Ca2+ in skeletal
muscle contractility, Ca2+ was removed from the
extracellular solution bathing intact, isolated extensor
digitorum longus (EDL, glycolitic mostly ast-twitch )
muscle fibers by chelation with 0.1 mM EGTA. Under
these conditions, we observed a decrease in the
contractile force following high frequency stimulation,
while the low frequency component is not significantly

However, to date, to the best of our knowledge, no
systematic studies have yet been performed to test if a
reduced SOCE function contributes to the decreased
contractile capacity of aged skeletal muscles.
Furthermore, it is not known if and how SOCE
contributes to normal muscle contractility, two essential
physiological questions that we aimed to answer in
these novel studies.
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Figure 1. Original and unfiltered recording of a SOL muscle from Wt mice illustrates robustness of our
preparations as it can undergo a multitude of experimental manipulations during a prolonged protocol
without signs of deterioration. (A) An entire protocol of more than 6h in duration in a soleus (SOL) muscle is shown.
The experimental points shown in this record are: a) Initial equilibration period where muscle is carefully stretched; b)
Force vs. frequency relationship, c) Equilibration, followed by solution change (from 2.5 mM Ca2+ to zero Ca2+ + 0.1 mM
2+
2+
2+
EGTA), d) Equilibration in Zero Ca , followed by change of solution back to 2.5 mM Ca , e) Recovery in 2.5 mM Ca , f)
Fatiguing stimulation, g) Recovery from fatigue in the absence of caffeine, h) Recovery in the presence of 20 mM caffeine,
i) After stimulation being stopped, the muscle is treated with 80 mM KCl and still produces a very large response to KCl
that approximates the maximal tetanic force. Preparation produced 11 g (~107 mN) of relative force. (B) A single muscle
fiber was dissected from the same intact SOL muscle shown in panel A. Single muscle fiber was the electrically stimulated
with 80 Hz. and produced ~ 0.12 mN of force. The same fiber was then chemically skinned with Triton X‐100 and
produced a maximal contractile force of ~ 0.12 mN. From our own observations, we estimate that a SOL muscle has ~925
muscle fibers; thus, the predicted contractile force for this preparation is ~111 mN (0.12 mN/fiber x 925 = 111 mN), which
is very similar to the relative force of 107 mN determined by the force calibration in our intact muscle system.

in the soleus (SOL, oxidative mostly slow-twitch)
muscle. We found that removal of extracellular Ca2+
actually produced a larger drop in contractile force in
young SOL as compared to young EDL muscles (Fig.
2C-D). Further evidence of the necessity of [Ca2+]o
entry in the maintenance of skeletal muscle contractility
is provided by a series of experiments that inhibit
[Ca2+]o entry through inclusion of NiCl2 in the extracellular solution, which has been shown to specifically
inhibit a component of Ca2+ entry in smooth muscle
cells that is not affected by either nifedipine or
verapamil, which suggest its selectivity to block the
SOCE machinery [23,24]. Since the experiments shown
in Fig. 2 were performed at ambient temperature (~25°C)

altered (Fig. 2A). This suggests that during high
frequency tetanic contractions, repetitive cycles of SR
Ca2+ release results in loss of Ca2+ from intracellular SR
stores to trigger entry of Ca2+ into muscle fibers. In
multiple experiments, we observed full recovery of
contractile force upon restoration of 2.5 mM [Ca2+]o by
washout of EGTA-containing solution (n=18/20) (Fig.
2B). Note that both the initial loss of force and recovery
after washout are rapid, suggesting that the effect of
[Ca]o may be related to direct shuttling of Ca2+ across
the sarcolemmal membrane through mechanisms that
these type of experiments are not able to reveal. Our
next step was to investigate if the extracellular Ca2+
dependence observed in EDL muscles was also present
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Figure 2. Removal of [Ca2+]o reduces tetanic contractile force in young skeletal muscle. (A) An Intact EDL
muscle was electrically stimulated with low and high frequency in a bath solution with either 2.5 mM [Ca]o (control) or 0
[Ca]o+0.1 mM EGTA. (B) An Intact SOL muscle was electrically stimulated with high frequency in a bath solution with
either 2.5 mM [Ca]o (control) or 0 [Ca]o+0.1 mM EGTA. Fast recovery upon return of preparations to 2.5 mM [Ca]o is
observed. (C) Data summary for the effects of 0 [Ca]o on EDL muscle at T = 25o C (n = 12, p < 0.01). (D) Data summary for
o
the effects of 0 [Ca]o on SOL muscle at T = 25 C (n = 10, p < 0.01).

sible after washout in the majority of the experiments
(Fig. 3B, n=9/11). Similarly, the SOL muscles also
displayed a component of contractile force that is
sensitive to inhibition by NiCl2 (Fig. 3C). As
summarized in Figs. 2D and 3D, SOL muscles
demonstrate a larger Ca2+ dependence component in
both Ca removal and SOCE blockade with Ni2+. As
with chelation of [Ca2+]o by EGTA we found that Ni2+
has more pronounced effects on the contractile force
developed during high frequency stimulation than
during low frequency stimulation, further suggesting

and physiological mechanisms may display dependence
on temperature, we conducted these contractility
experiments involving NiCl2 at the 37°C to establish the
extent to which Ca2+ entry effects contraction at
physiologically normal temperature (Fig. 3). These
experiments revealed that a similar effect of [Ca2+]o
entry on contractility can be observed at physiological
temperatures. As shown in Fig. 3A, addition of 1 mM
Ni2+ to the extracellular solution results in a nearly
instantaneous drop in the contractile force of isolated
EDL muscles. The effect of Ni2+ was completely rever-
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that under conditions of high Ca2+ demand, [Ca2+]o
exerts a more significant role in skeletal muscle
contractility. An intriguing observation during the
NiCl2 experiments was the transient increase in the
low frequency force (Fig. 3A). It is possible that at
these lower frequencies, the addition of Cl- induced
Ca2+ release from the SR, a phenomenon previously
reported by Stephenson et al [25]. This result actually
provides very strong evidence that a drop in force at
higher frequencies of stimulation in response to NiCl2
is not artifactual. From the measurement of forcefrequency relationship, one can clearly see that Ni2+
effects were more pronounced at higher frequencies of
stimulation (Fig. 4A) supporting the concept that SOCE

may contribute to DPH muscle contractility under
conditions of higher demand, which might have
important clinical implications, since DPH fatigue can
lead to serious disease and death. In Fig. 4B, DPH
muscles were contracted with a high frequency of
200Hz. Clearly, a fast initial drop in force within 1min
is easily detected. This initial drop in force is followed
by an additional time-dependent force reduction
component, since a further reduction in force is
observed in the following 8min of exposure to Ni2+
(Fig. 4B). These data further confirm our findings in
EDL and SOL muscles, and suggest that SOCE
response is a universal phenomenon in different
muscle types of young animals.

Figure 3. Extracellular Ni2+ reduces tetanic force in young skeletal muscle. (A) An intact EDL muscle was
electrically stimulated at 37°C with low frequency and high‐frequency in a bath solution with 2.5 mM [Ca]o (control) and
following addition of 1 mM NiCl2. Ni inhibits force generated with high‐ but not low‐frequency stimulation. (B) An intact SOL
muscle was electrically stimulated at 37°C with high‐frequency in a bath solution with 2.5 mM [Ca]o (control) and following
addition of 1mM and 5mM NiCl2. A cumulative effect to NiCl2 is noted. (C) Data summary for the effects of NiCl2 on EDL
o
o
muscle at T = 37 C (n = 8, p < 0.01). (D) Data summary for the effects of NiCl2 on SOL at T = 37 C (n = 6, p < 0.01).
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Figure 4. Effects of Ni2+ on contractility of young diaphragm muscle. (A) Force vs. frequency relationship in control
diaphragm muscles (open circles) or diaphragm muscles treated with NiCl2 (solid circles). (n = 3). (B) Intact diaphragm
muscle bundles from young mice were electrically stimulated at 37°C with high frequency (200 Hz/min) in the absence
(open circles, control) or in the presence of 3 mM NiCl2 (solid circles, NiCl2).

les, and stands in stark contrast to the significant
contribution of [Ca2+]o to acute contractility in young
muscle.

Aged skeletal muscle displays reduced contractile
force and negligible [Ca2+]o dependence
Extending our contractile measurements to preparations
of EDL muscles from aged mice, we first confirmed our
previously determined decrease of ~30% in normalized
specific contractile force in this tissue (Fig. 5A). Since
this reduction in force is already normalized to the
different cross-sectional areas of young and aged
muscles, such difference is independent of age related
atrophy. These experiments revealed quite surprising
phenotypic changes in aged muscle – a remarkable
suppression of the sensitivity of aged muscle to
inhibition of contractile force by inhibition of [Ca2+]o
entry. As illustrated in Fig. 5B, there are no detectable
effects of Ni2+ on the high-frequency tetanic force in
aged muscles. Similarly to the young muscles, Ni2+ had
a tendency to increase the low frequency force, but by
the end of the recovery force the low frequency force
returned to its control levels. Over the course of several
experiments, we found only negligible effects of
extracellular Ni2+ on muscle contractility (Fig. 5C).
Additionally, we found that chelating [Ca2+]o with
EGTA had no significant acute impact on the contractile
function of aged EDL skeletal muscle (Fig. 5D).
Complementary experiments in aged soleus muscle
demonstrated similar effects of Ni2+ and 0[Ca2+]o on
contractility (Fig. 5D). These results indicate that the
acute functional contribution of [Ca2+]o to skeletal
muscle contractility is impaired in aged skeletal musc-

www.impactaging.com

Mechanisms of loss of Ca2+-dependence in aged
skeletal muscle
Our results indicate that the dependence of skeletal
muscle on [Ca2+]o is lost in aged muscle. Elucidation of
the mechanism contributing to this loss of Ca2+dependence may provide a therapeutic target for
increasing contractile force and function in aged
skeletal muscle or perhaps new insights into the
prevention of muscle loss in young subjects during
aging. To establish whether the effect of [Ca2+]o entry
on contractility of young skeletal muscle was mediated
by the L-type Ca2+ channel, we incubated the EDL or
soleus muscles with nifedipine, an inhibitor of this
channel, at a concentration (10 μM) previously shown
to block Ca2+ entry via the L-type Ca channel during
excitation-coupled Ca2+ entry (ECCE) in C2C12
myotubes [26] As shown in Fig. 6, there was no
significant decrease in contractility observed with up to
13 minutes of exposure to nifedipine, a finding in
agreement with previous reports from Reid et al.
[27;28]. Therefore, the mechanism that underlies
[Ca2+]o entry contribution to contractility is likely to
involve pathways other than those linked to the L-type
channels.
Our findings further suggest that this
mechanism must be functional in skeletal muscle from
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young, but not aged, individuals. Considering our
previous findings indicate compromised SOCE in aged
skeletal muscle, we hypothesize that SOCE could be one
such pathway. To test this hypothesis, we examined how
abrogated SOCE might affect force production in young
and aged skeletal muscle. First, we examined the effects
of BTP-2, which has been shown to be a specific blocker
of SOCE in skeletal muscles [29], on contractility of

young and aged muscle. We found that BTP-2 reduce the
high frequency tetanic force produced by EDL and SOL
muscles from young mice (Fig. 7A and 7B), further
suggesting that a component of force generation in
young, healthy skeletal muscles derives from functional
SOCE. In striking contrast, BTP-2 did not have
noticeable effects on the contractile force generation of
aged EDL and SOL muscles (Fig. 7C and 7D).

Figure 5. Reduced specific force in aged skeletal muscle associates with blunted [Ca2+]o dependence.
(A) Maximal tetanic force normalized to the cross sectional area in young (red) and aged (green) EDL muscles (n =
12, * p < 0.001). (B) Intact EDL muscle from aged mice subjected to the same protocol as in Figs 2‐3, demonstrates
that NiCl2 lacks an effect in aged muscle. (C) Summary data for the effects of NiCl2 and washout after treatment (n
= 8). (D) Summary data for the effects of 0[Ca2+]o and washout after treatment (n = 6).
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reduce the high-frequency force production of young
EDL muscle (Fig. 10A), providing additional
pharmacological evidence that extracellular Ca2+ is
linked to force production in skeletal muscle. When
these experiments are conducted with aged skeletal
muscle there is no decrease in contractile force
following BEL application (Fig. 10B). Thus, the SOCEdependent component of skeletal muscle contractility
that is present in young skeletal muscle is no longer
active in aged skeletal muscle, and parallels at least part
of the loss of the contractile force in this tissue [13] (see
also figures in the manuscript indicating the atrophyrelated and atrophy-independent components of force
generation in aged muscles and accompanying Editorial
Commentary).

DISCUSSION
Figure 6. L‐type/DHPR inhibition does not explain ex‐
tracellular Ca+2 dependence in young skeletal muscles.

As aging populations grow world-wide (It has been
estimated that by 2050 more than 200 million humans
will have sarcopenia), the aging-related decline in
muscle function becomes a more pressing public health
concern that requires more effective therapeutic
approaches, which in turn requires an understanding of
sarcopenia at a mechanistic level. While a portion of the
decrease in muscular strength during aging can be
explained by muscle atrophy, it is clear that other
components contribute to reduced force production
during aging. Furthermore, it is unquestionable that an
array of cellular modifications [8-13] may contribute to
muscle aging, and the pleiotropic nature of muscle
aging muscle be recognized and accepted if we are to
make significant progress towards its prevention and
management.

Intact EDL muscle from young mice subjected to the low/high
frequency stimulation protocol demonstrates that 10 µM
nifedipine lacks an effect in young muscle.

Previous studies by Bolotina and colleagues [30,31]
showed that bromoenol lactone (BEL) is a potent
inhibitor of SOCE, while studies by Gong and Reid
found that BEL can reduce contractile force in skeletal
muscle from young adult mice [32]. Thus, a series of
studies were conducted a series of experiments to test if
inhibition of SOCE by BEL produced differential
effects on contractility in young or aged skeletal muscle
fibers. Since BEL has not been used to inhibit SOCE in
primary skeletal muscle, we first validated that BEL
was effective under these conditions. We conducted
Ca2+ imaging studies in individual flexor digitorum
brevis (FDB) muscle cells to measure SOCE using
Mn2+-quenching of Fura-2 fluorescence to measure
SOCE [33]. Our data with young isolated FDB muscle
fibers revealed that 25 µM BEL could almost
completely inhibit SOCE elicited by depletion of the SR
stores
using
thapsigargin
(TG)
or
Ca2+
caffeine/ryanodine treatment (Fig. 8). Knowing that
BEL acted as a very effective blocker of SOCE in
young FDB muscle cells, we then used mechanicallyskinned muscle fibers to monitor Ca2+ exit from the Ttubules via SOCE using the fluorescence of Rhod-5N
trapped in the T-tubule space as a reporter [16,34].
Under these conditions, BEL effectively blocked SOCE
as monitored with confocal imaging of Rhod-5
fluorescence in young muscle fibers (Fig. 9A), but had
negligible effect in aged ones (Fig. 9B). Our last series
of experiments was to investigate the effects of BEL in
contractility experiments, and we found that BEL can
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While the role of SOCE during aging is largely
unexplored, we recently had established the novel
finding that SOCE is compromised in aged skeletal
muscle [16], but our inaugural studies failed to directly
link reduced SOCE in aged muscles with decreased
contractile force in aged muscles. Now, our new data
reveals that a functionally significant, SOCE-dependent
component of skeletal muscle contractility in young
muscle is lost in aged skeletal muscle. A viable
hypothesis for atrophy-independent muscle weakness in
aging, therefore, involves substantial abrogation of
SOCE, a process vital to the full functionality of E-C
coupling.
Our studies indicate that in young skeletal muscle,
SOCE contributes to maintenance of contractile force
under high frequency stimulation, where Ca2+
requirements may exceed the capacity of the
intracellular store to provide for sustained and repetitive
contractions, almost as if there is a fatigue component to
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the SOCE regulation of contractile force. The fact that
force generation in skeletal muscle from aged animals is
significantly reduced under conditions of high-frequency
stimulation suggest that this tissue has lost its ability to
use [Ca2+]o during periods of increased demand, a

phenomenon we recently introduced [18]. Our data now
suggests that SOCE is actually required for repetitive
stimulation of skeletal muscles, and its loss in aging
significantly contributes to the loss of contractile
function in the skeletal muscle.

Figure 7. BTP‐2, a selective and potent inhibitor of SOCE reduces contractile force in young but not in
aged skeletal muscle. (A) Intact EDL muscle stimulated with low and high frequencies every minute at 37ºC; in
control (no drug) contractions are shown, followed by the progressive effect of 20 µM BTP‐2. On average the
decrease in force with 20 µM it was 19 ± 4%. (B) Same protocol as in panel A, but using young SOL muscles,
representative of 3 experiments. In these 3 experiments force decreased by 31 ± 7% in 15 min in SOL muscles. (C)
EDL muscles from aged Wt mice were equilibrated with 30 and 80 Hz under control condition and then were
exposed to 20 µM BTP‐2. (D) SOL muscles from aged WT mice tested with the same protocol as shown for aged EDL
muscles in panel C. No statistical differences between control and BTP‐2 were seen in aged EDL and SOL muscles.
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Figure 8. Mn+2 quenching of Fura‐2 in FDB muscles of
young muscle validates the use of BEL as an effective
SOCE blocker. Enzymatically dissociated FDB muscle fibers
were tested for their SOCE activity using the Mn+2 quenching
assay. BEL was able to block most 90% of the SOCE response
under these experimental conditions.

Intriguingly, reduced SOCE during the aging process is
not a phenomenon limited to skeletal muscles, but is
also present in other tissues, such as fibroblasts and
neuronal cells [35,36]. In addition, it is clear from the
recent report by Stiber, that STIM1, and hence SOCE, is
required for the normal development of skeletal muscle
[22]. Our findings that [Ca2+]o contributes directly to
contractility in young skeletal muscles is different than
previous findings - that [Ca2+]o does not normally
contribute to skeletal muscle contractility, except in a
subpopulation of aged muscle fibers [37]. This may be
due to the fact that most of the earlier studies suggesting
a relative lack of effect of [Ca2+]o on muscle
contractility were not performed under conditions that
could allow detection of the effect that we observe,
including the fact that many of these studies were
performed in amphibian muscle, and also in some cases,
these studies were conducted in single muscle fibers
that might behave in ways that are different from the
intact, anatomical muscle. Also, since Delbono and
collaborators showed that a subpopulation of aged
muscle fibers were dependent on extracellular calcium
entry, while another subpopulation was not dependent
on extracellular calcium entry, it does make sense that
in a intact muscles, where all muscle fibers are
combined, such difference is not observed.
Furthermore, our results come from use of a previously
unexploited high-frequency stimulation (using 80-200
Hz of 500-1000ms duration, with single pulses of 1ms
duration) paradigm that mimics states when demand for

www.impactaging.com

Figure 9. Direct visualization of SOCE in mechanically EDL
skinned muscle fibers of young and old muscles with BEL
reveals robust SOCE in young but compromised SOCE in
aged muscle. Confocal imaging of Ca movement from the
sealed T‐tubules of mechanically skinned muscle fibers from
young and aged mice demonstrates that SOCE is fully function in
young, but severely ablated in aged muscle fibers.

Ca2+ is high to elucidate the functional effects of SOCE
on the contractility of three distinct intact muscle types
(EDL, soleus and diaphragm) from mice. In addition,
more potent SOCE inhibitors are now available and
utilization of a small but effective concentration of 0.1
mM EGTA in the zero Ca+2 solution was critical for full
observation of these effects, likely required to buffer the
large amount of calcium in the T-tubular system. One of

630

AGING, June 2011, Vol.3 No.6

Figure 10. BEL reduces contractile force in young but not in aged skeletal muscle. Intact EDL and SOL muscles
from young and aged muscles reveal that this agent is able to reduce the contractile force in only young muscles.

our most significant findings is that skeletal muscle
contractile function under conditions of low-frequency
stimulation remains mostly [Ca2+]o-independent, while
significant contribution of SOCE to contractility is
more prominent under high frequency stimulation. In
line with our hypothesis that there is a loss of functional
SOCE in aged muscle, there was no effect on force by
the application of EGTA, NiCl2, BTP-2, and BEL in
aged muscle. The utilization of ex vivo, intact isolated
muscles offers the advantage of robust preparations, as
evidenced by our previous report that LDH is
essentially undetectable in the extracellular bathing
solution of our preparations [38,39]. Our findings
indicate that the SOCE-dependent component of
contractility we observed in young muscle is lost in
aged muscle, which also display reduced SOCE activity
(See Figs 8-9 and [16]). Such findings provide the
possibility that increasing SOCE activity in aged muscle
may restore this lost component of contractile force and
increase force generation. In light of our present results
and our recent work with MG29 null mice [16,17], the
parallels between defective SOCE and reduced MG29
levels in aged skeletal muscle may be of significant
physiological import. Indeed, these findings suggest that
modulation of MG29 function in aged skeletal muscle
provides a potential therapeutic target to enhance SOCE
and increase muscle contractility in aged patients. This
finding is further supported by the recent association of
mitsugumins in human muscle diseases [40]. Yet,
another molecule of interest might be MIP/MTMR14,
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since we recently showed that mice lacking this
molecule display phenotypic muscle changes that mirror
muscle wasting and muscle weakness during aging [13].
In summary, we show for the first time that SOCE plays
a significant role in normal contractility in young,
healthy skeletal muscle. In striking contrast, in aged
skeletal muscle, we now show that compromised SOCE
is linked to decreased contractile force. We postulate
that a chronically compromised SOCE leads to an
equally chronic reduction in the amount of Ca2+ stored
in the SR, creating a negative feedback loop, less Ca2+
is available, less is released, with less force being
produced. Interestingly, the absolute force produced by
young, healthy muscles when SOCE is inhibited
approximates the amount of force produced by aged
muscles. Thus, SOCE should be seen as an important
functional biomarker of muscle function during aging,
and it may provide a suitable target for therapeutic
intervention for muscle diseases. Whether the loss of
SOCE contributes to muscle atrophy during sarcopenia,
or whether it is the reflection of the pleiotropic adaptive
response during aging, is still very much an open
question.

MATERIALS AND METHODS
Muscle Preparation [17,34,41]. Intact extensor
digitorum longus (EDL), diaphragm (DPH) and soleus
(SOL) muscles of wild type (Wt) male mice, 5 and 24
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Ca2+], FDB muscle fibers were enzymatically isolated in
a 0 Ca2+ Tyrode solution containing 2 mg/mL type I
collagenase for 2 hours in a shaking bath at 37 °C,
before being transferred to a 0 Ca2+ Tyrode solution
without collagenase and gently triturated with a pipette.
The fibers were then loaded with 5 µM Fura-2-AM for
40 minutes, after which the Fura-2 AM was washed off.
As fiber motion artifacts are associated with
intracellular Ca release, 20 µM N-benzyl-p-toluene
sulfonamide (Sigma, St. Louis, MO), a specific myosin
II inhibitor, was then applied for 20 minutes. A dualwavelength (excitation at 340 nm and 380 nm) PTI
spectrofluorometer (Photon Technology International,
Birmingham, NJ) was used to determine the kinetic
changes of caffeine and ryanodine (C/R)-induced
intracellular Ca2+ transients.

month old, were surgically removed from tendon to
tendon by blunt dissection and immediately placed in a
dissecting dish containing a modified bicarbonate
Ringer solution with the following compositions (mM).
In the case of the DPH, small bundles were prepared in
such a way that they could be mounted from the rib
cage and the central tendon. The pH was adjusted to
between 7.4 with NaHCO3, followed by the addition of
fetal bovine serum (to 0.2%) to increase viability of the
dissected muscle. The solution was continuously
aerated with a gas mixture consisting of 95% O2 and 5%
CO2. EDL and SOL muscles were mounted vertically
between two Radnoti (Monrovea, CA, USA) stimulating platinum electrodes and immersed in a 20 mL
bathing chamber containing the incubation medium.
The muscles were suspended from movable isometric
force transducers above the chambers via the tendons,
and secured to the base of the tissue support within the
chambers. The analog output of the force transducer
was digitized, stored and analyzed with PowerLab
Software (Colorado Springs, CO, USA). For each
muscle, the resting tension and the stimulatory voltage
were provided by a Grass S8800 digital stimulator
(West Warwick, RI, USA) and both parameters were
adjusted to produce a maximal isometric tetanic force
(Tmax).

Mn2+ quenching experiment were performed as
previously described with minor modifications. Briefly,
FDB fibers were loaded with Fura-2/AM fluorescent
Ca2+ indicator [16]. SR Ca2+ depletion with C/R (with
and without 25 µM BEL) was followed by the addition
of 0.5 mM MnCl2 (with and without 25 µM BEL) to the
extracellular solution. The Mn2+ quenching of Fura-2
fluorescence was measured at the Ca2+-independent
wavelength of Fura-2AM excitation (360 nm). The
decay of Fura-2AM fluorescence upon Mn2+ addition
was expressed as percent decrease in Fura-2
fluorescence per unit time.

Intact Muscle Protocol . After initial Tmax determination,
the muscles were subjected to a protocol that mimics
normal muscle activity (No fatigue, stimulation trains
triggered at every minute, duty cycle of 2%). Muscles
were placed in 2.5 mM Ca or zero Ca2+ and/or 5 mM
NiCl2, 1 mm NiCl2, 10 μM nifedipine, or 25 μM
bromoenol lactone (BEL). The intact muscles were
allowed a 30-minute equilibration, during which time
they were stimulated with pairs of alternating high (that
produced Tmax) and low (that produced 1/2 Tmax)
frequency pulse-trains administered with a periodicity
of 1 minute, before any pharmacological intervention
was attempted. The results indicate the relative
contributions from the contractile proteins (Tmax) and
from the SR (1/2 Tmax) to the stimulation [41].

Confocal Imaging of Store-operated calcium entry in
mechanically-skinned muscle skinned muscle fiber.
These studies followed our own protocols, which are
based on our original and first ever methodology to
directly monitor the spatial and temporal resolution of
SOCE in mammalian skeletal muscle fibers [16,34].
Briefly, intact muscle fibers are carefully skinned in the
present of 0.5mM CaCl2 and Rhod-5N, forcing the
trapping of the dye and Ca+2 in the re-sealed T-tubules.
Using IDL driven sub-routines, areas of interest
comprising either the T-tubules or background areas can
be drawn and the relative fluorescence upon activation of
SOCE can be quantified. A minimum of 6 ROIs from
each muscle fiber from 9 muscle fibers from 3 mice was
employed to obtain the average SOCE activity in young
and aged mice.

Intracellular Ca2+ Measurement and Mn2+ Quenching
[33]. For quantitative measurements of intracellular
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